Get the Stockscreener App
3.61
6.72%
-0.26
Omeros Corporation stock is traded at $3.61, with a volume of 1.86M.
It is down -6.72% in the last 24 hours and up +21.55% over the past month.
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
See More
Previous Close:
$3.87
Open:
$3.83
24h Volume:
1.86M
Relative Volume:
1.54
Market Cap:
$211.52M
Revenue:
-
Net Income/Loss:
$-117.81M
P/E Ratio:
-1.9202
EPS:
-1.88
Net Cash Flow:
$74.30M
1W Performance:
-5.74%
1M Performance:
+21.55%
6M Performance:
-58.12%
1Y Performance:
-28.09%
1-Day Range:
$3.52
$3.83
1-Week Range:
$3.52
$4.45
52-Week Range:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Name
Omeros Corporation
Sector
Industry
Phone
206-676-5000
Address
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
3.61 | 259.78M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-25 | Initiated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Dec-08-22 | Downgrade | UBS | Buy → Neutral |
| Nov-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-08-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-08-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-21 | Downgrade | Maxim Group | Buy → Hold |
| Oct-01-21 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-27-21 | Initiated | JP Morgan | Neutral |
| Feb-01-21 | Initiated | UBS | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Aug-21-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-14-20 | Reiterated | Maxim Group | Buy |
| May-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-12-18 | Initiated | Seaport Global Securities | Buy |
| Mar-23-18 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-05-18 | Downgrade | Needham | Buy → Hold |
| Nov-08-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| Mar-17-17 | Reiterated | Maxim Group | Buy |
| Mar-17-17 | Reiterated | Needham | Buy |
| Nov-16-16 | Reiterated | Wedbush | Outperform |
| Nov-10-16 | Reiterated | Needham | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Jun-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-02-16 | Reiterated | Needham | Buy |
| Feb-29-16 | Reiterated | Wedbush | Outperform |
| Nov-11-15 | Reiterated | Needham | Buy |
| Aug-18-15 | Reiterated | WBB Securities | Strong Buy |
| Aug-10-15 | Initiated | ROTH Capital | Buy |
View All
Omeros Corporation Stock (OMER) Latest News
Why Omeros Corporation stock attracts strong analyst attentionFree Real Time Trade Opportunity Alerts - Newser
What catalysts could drive Omeros Corporation stock higher in 2025Top Growth Planner That Work - jammulinksnews.com
Best data tools to analyze Omeros Corporation stockFree Daily Profit Focused Stock Screener - Newser
New Product Launches: Will They Boost Omeros Corporation Stock in 2025Free Consistent Profit Pattern Recognition Tools - Newser
Signal strength of Omeros Corporation stock in tech scanners3-Day Market Movement Forecast Analysis - Newser
How does Omeros Corporation generate profit in a changing economyChart Pattern Insights Backed By Experts - jammulinksnews.com
D. Boral Capital Acted as Exclusive Placement Agent to Omeros Corporation (Nasdaq: OMER) in Connection with its $22,000,000 Registered Direct Offering - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Omeros Corporation (NASDAQ:OMER) - Defense World
Trend analysis for Omeros Corporation this weekReliable Setup Screener with Low Risk - Newser
Moving Average Trends for Omeros Corporation Stock: What They IndicateTechnical Stock Breakout Predictions Signal Entry Points - metal.it
How Omeros Corporation stock performs during market volatilityPrice Movement and Market Sentiment Analysis - Newser
Visual analytics tools that track Omeros Corporation performanceExit Strategy Guide With Risk Control Plan - Newser
Backtesting results for Omeros Corporation trading strategiesFree Safe Entry Stock Watch Suggestions - Newser
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN
Omeros Shares Rise After $22 Million Direct Offering Prices - 富途牛牛
Is Omeros Corporation a Top Dividend Stock to Watch in 2025Free Proven Entry Plan With Low Risk Trade - Newser
How strong is Omeros Corporation company’s balance sheetFree Stock Recommendation From AI Tools - jammulinksnews.com
These Numbers Prove Just How Vibrant The Omeros Corporation (NASDAQ: OMER) Stock Has Been - Stocksregister
Is Omeros Corporation a growth stock or a value stockProven strategies for superior portfolio growth - jammulinksnews.com
Is it the right time to buy Omeros Corporation stockUnlock powerful stock screening techniques - jammulinksnews.com
Real time scanner hits for Omeros Corporation explainedMomentum Stocks with Breakout Potential - Newser
What institutional investors are buying Omeros Corporation stockExplosive earning power - jammulinksnews.com
How to read the order book for Omeros CorporationLong-Term Growth Trend Summary With Confidence - Newser
Trend analysis for Omeros Corporation this week Free Short Term Buy Zone Stock Alerts - Newser
New York State Common Retirement Fund Sells 5,900 Shares of Omeros Corporation (NASDAQ:OMER) - Defense World
What makes Omeros Corporation stock price move sharplyFast-track wealth growth - jammulinksnews.com
How many analysts rate Omeros Corporation as a “Buy”Unlock real-time stock alerts for quick profits - jammulinksnews.com
When is Omeros Corporation stock expected to show significant growthHigh-yield portfolio picks - jammulinksnews.com
Omeros Corporation (NASDAQ:OMER): When Will It Breakeven? - 富途牛牛
Omeros (NASDAQ:OMER) Earns Buy Rating from D. Boral Capital - Defense World
Omeros announces pricing of $22 million registered direct offering - MSN
FY2025 EPS Estimates for Omeros Cut by Cantor Fitzgerald - Defense World
Traders Purchase High Volume of Call Options on Omeros (NASDAQ:OMER) - Defense World
Omeros Corporation Announces Pricing of $22 Million Registered D - GuruFocus
Omeros (OMER) Announces $22 Million Stock Sale to Polar Asset Ma - GuruFocus
Omeros (OMER) Stock Rating and Price Target Maintained by D. Boral Capital | OMER Stock News - GuruFocus
Omeros Secures $22 Mln In Registered Direct Offering With Polar Asset Management - Nasdaq
Is Omeros Corporation a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
Omeros stock rises after $22 million registered direct offering By Investing.com - Investing.com Canada
Omeros stock rises after $22 million registered direct offering - Investing.com
Omeros Stock Soars 8.91% on $22M Equity Offering - AInvest
Omeros rises after pricing ~$22M stock offering - MSN
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | OMER Stock News - GuruFocus
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | - GuruFocus
Omeros to raise $22 million in registered direct offering By Investing.com - Investing.com South Africa
Omeros Corporation Stock (OMER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):